Geovax Labs Inc

-0.04 (-1.01%)

Geovax And City Of Hope Announce Deal To Accelerate Development And Commercialization For City Of Hope's COVID-19 Vaccine

Published: 11/09/2021 21:21 GMT
Geovax Labs Inc (GOVX) - Ric:cohi.
Ul]:geovax and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope's Covid-19 Vaccine.
Geovax Labs Inc - Phase 2 Vaccine Designed to Enhance Response for Immunocompromised Patients.
Geovax Labs Inc - Financial Terms of Transaction Were Not Immediately Disclosed.
Geovax Labs - Agreement Grants Geovax Exclusive Rights to Further Develop and Commercialize a Multi-antigenic Sars-cov-2 Investigational Vaccine.
Geovax - License Provides Exclusive Worldwide Rights to Key Patents, As Well As Certain Rights to Expertise & Clinical Materials, Related to Coh04s1.
Geovax Labs - in a Placebo-controlled Phase 1 Clinical Trial of Healthy Adults, Coh04s1 Was Shown to Be Safe and Immunogenic.